Health Tech Capitol | FCDI to build $21M stem cell production facility in Madison
16494
post-template-default,single,single-post,postid-16494,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

FCDI to build $21M stem cell production facility in Madison

04 Jan FCDI to build $21M stem cell production facility in Madison

Posted at 12:02h in Uncategorized by
0 Likes

Fujifilm Cellular Dynamics Inc. (FCDI) plans to invest $21 million to create a facility in Madison for manufacturing stem cell therapies that can be used as regenerative medicine — cells that can repair or rebuild a patient’s diseased or damaged tissue.

FCDI manufactures human induced pluripotent stem cells (iPSCs), which are skin or blood cells that scientists reprogram back into their embryonic state and then coax into specific cell types for use in scientific research or drug development.

FCDI is remodeling 31,500 square feet of space in a building at 465 Science Drive, near the company’s current labs and offices at 525 Science Drive, in University Research Park, to house the new stem cell production, which will meet U.S. Food and Drug Administration manufacturing requirements.

Read more at the Wisconsin State Journal

No Comments

Sorry, the comment form is closed at this time.